|
|
| Volume 18 • Issue 3 |
February 7, 2018 |
 |
|
|
 |
 |
| |
 |
|
|
IMPORTANT INFORMATION
TEMPORARY BACKORDER OF MYOCHRYSINE® 25 MG/ML AND 50 MG/ML
(SODIUM AUROTHIOMALATE)
Sanofi-aventis Canada Inc. would like to update the information we previously provided regarding the temporary backorder of Myochrysine® 25 mg/ml and 50 mg/ml (sodium aurothiomalate) due to a supply issue for the active ingredient.
Read more
|
|
|
|
| |
 |
|
|
ASTRAZENECA RESPIRATORY – PATIENT SUPPORT
Resources for TUDORZA® GENUAIR® now available.
Read more
|
|
 |
| |
 |
|
|
COLD-FX® HAS A NEW DRESS CODE
Click here to see our redesigned packaging.
|
|
 |
| |
 |
|
|
BY AGE 40, ABOUT 50% OF THE POPULATION WILL HAVE OR HAVE HAD
A MENTAL ILLNESS
Read more
|
|
|
|
| |
 |
|
|
PREVENTION AND TREATMENT OF IRON DEFICIENCY
Read more
|
|
|
|
|
|
